Literature DB >> 20336352

Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.

Karen Freitas Santos1, Vanessa Battisti, Maísa de Carvalho Corrêa, Thaís Rapachi Mann, Renata da Silva Pereira, Maria do Carmo Araújo, Alice Odete Brülê, Maria Rosa Chitolina Schetinger, Vera Maria Morsch.   

Abstract

Von Willebrand disease (VWD) is one of the most common inherited bleeding diseases caused by a qualitative or quantitative deficiency of the von Willebrand factor (FvW). FvW is a multimeric glycoprotein synthesized by megakaryocytes and endothelial cells and it is present in the subendothelial matrix, blood plasma, platelets, and endothelium. This glycoprotein plays an important role in thrombus formation by initiating platelet adhesion to sites of injury as well as platelet aggregation. The aim of this study was to evaluate the activities of enzymes that hydrolyze adenine nucleotides in platelets, ristocetin-induced platelet aggregation (RIPA), and polymorphisms of the alpha2 gene of alpha2beta1 integrin from VWD patients. Platelet nucleoside triphosphate diphosphohydrolase (NTPDase), 5'-nucleotidase, and ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP) activities were verified in 14 VWD patients. For RIPA determination, a final concentration of 1.25 mg/ml of ristocetin was used. Polymorphisms of the alpha2 gene were analyzed through PCR. Platelet NTPDase and E-NPP were decreased in VWD patients. 5'-Nucleotidase activity was not statistically significant between controls and VWD patients. RIPA was significantly reduced, with an allelic frequency of 78.57% for 807C in VWD patients. Our results indicated reduced platelet NTPDase and E-NPP activities which might be related to the low platelet adhesiveness. The prevalence of the 807C allele might account for the variability in bleeding in VWD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336352     DOI: 10.1007/s11010-010-0424-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  46 in total

1.  Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies.

Authors:  Gilberto Inácio Lunkes; Daniela Lunkes; Francieli Stefanello; André Morsch; Vera Maria Morsch; Cinthia Melazzo Mazzanti; Maria Rosa Chitolina Schetinger
Journal:  Thromb Res       Date:  2003-02-15       Impact factor: 3.944

2.  Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density.

Authors:  M Kritzik; B Savage; D J Nugent; S Santoso; Z M Ruggeri; T J Kunicki
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

Review 3.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

4.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

5.  Spectrum of von Willebrand's Disease: a study of 100 cases. Italian Working Group.

Authors: 
Journal:  Br J Haematol       Date:  1977-01       Impact factor: 6.998

Review 6.  Assessing bleeding in von Willebrand disease with bleeding score.

Authors:  Alberto Tosetto; Giancarlo Castaman; Francesco Rodeghiero
Journal:  Blood Rev       Date:  2006-06-13       Impact factor: 8.250

7.  Allelic distribution of the glycoprotein Ia (alpha2-integrin) C807T/G873A dimorphisms among caucasian venous thrombosis patients and six racial groups.

Authors:  D M Dinauer; K D Friedman; M J Hessner
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

8.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

9.  Platelet glycoprotein Ia 807C/T (Phe224) and 873G/A (Thr246) dimorphisms in Turkey.

Authors:  Evrim Komurcu; Nihan Erginel-Unaltuna
Journal:  Am J Hematol       Date:  2002-01       Impact factor: 10.047

10.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.